Innovate Biopharmaceuticals, Inc.
(NASDAQ : INNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.21%89.721.3%$813.69m
AMGNAmgen Inc.
1.05%187.451.2%$635.60m
GILDGilead Sciences, Inc.
0.31%65.750.9%$483.76m
BIIBBiogen Inc.
0.80%323.751.3%$430.88m
ILMNIllumina, Inc.
1.55%301.473.5%$316.17m
REGNRegeneron Pharmaceuticals, Inc.
0.79%421.922.6%$292.47m
VRTXVertex Pharmaceuticals Incorporated
0.98%184.851.9%$256.06m
ALXNAlexion Pharmaceuticals, Inc.
0.43%128.102.0%$220.63m
SRPTSarepta Therapeutics, Inc.
1.36%138.3915.4%$154.39m
AAgilent Technologies, Inc.
0.09%77.961.6%$150.94m
EXASExact Sciences Corporation
6.10%88.3625.3%$140.35m
INCYIncyte Corporation
1.20%84.332.5%$113.28m
ARRYArray BioPharma Inc.
3.04%23.408.2%$111.29m
EXELExelixis, Inc.
0.80%21.396.4%$82.72m
NBIXNeurocrine Biosciences, Inc.
1.09%78.155.1%$78.06m

Company Profile

Innovate Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing novel medicines for autoimmune inflammatory disease. The company is founded by Jay Madan in 2012 and is headquartered in Raleigh, NC.